Immunologic aspects of osteosarcoma and their application to therapy. A preliminary report.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000951:Antigens, Neoplasm / Q000302:isolation & purification*; D001798:Blood Proteins; D001859:Bone Neoplasms / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D000939:Epitopes; D005260:Female; D005266:Femoral Neoplasms / Q000276:immunology / Q000473:pathology; D005452:Fluoresceins; D006801:Humans; D007106:Immune Sera; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007167:Immunotherapy; D007223:Infant; D007958:Leukocyte Count; D008175:Lung Neoplasms; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D012516:Osteosarcoma / Q000276:immunology* / Q000473:pathology; D011817:Rabbits; D012882:Skin Tests; D013752:Tetracycline / Q000627:therapeutic use; D013977:Tibia / Q000473:pathology
D000951:Antigens, Neoplasm; D001798:Blood Proteins; D000939:Epitopes; D005452:Fluoresceins; D007106:Immune Sera; D013752:Tetracycline